Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against...
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against...
Two years after its acquisition of PillPack, Amazon has further expanded its presence in the...
Synthetic control arms could transform clinical development as they allow companies to overcome in the...
The Serum Institute of India (SII) expects to soon receive World Health Organisation (WHO) emergency...
Research consortium COG-UK has been coordinating work across the UK to sequence the whole genome...
Immuneering has raised $62m in an oversubscribed Series B round led by high-profile life science...
The Swiss Agency for Therapeutic Products, Swissmedic, has authorised the Moderna’s Covid-19 vaccine in Switzerland.
EY’s 2021 M&A Firepower report considered the ups and downs of biopharma M&A in 2020...
Simultaneous to the emergency approval of a second Covid-19 vaccine, UK healthcare regulator the MHRA...